Emami will hold a meeting of the Board of Directors of the Company on 29 May 2024.Powered by Capital Market - Live News

Emami holds 95.36% in the paid up capital of its subsidiary Company, Brillare Science (Brillare). The Company has further entered into Share Purchase Agreement with the founder & other shareholders of Brillare for acquiring remaining stake of 4.64 % of that Company. Consequently, Emami`s Shareholding in Brillare has increased from 95.36% to 100% and it has become a wholly owned subsidiary of the Company. Powered by Capital Market - Live News

Emami announced that the Board of Directors of the Company at its meeting held on 9 February 2024, has recommended a Second Interim dividend of Rs.4 per share (i.e.400%), subject to the approval of the shareholders.Powered by Capital Market - Live News

Net profit of Emami rose 8.97% to Rs 258.41 crore in the quarter ended December 2023 as against Rs 237.13 crore during the previous quarter ended December 2022. Sales rose 1.38% to Rs 996.32 crore in the quarter ended December 2023 as against Rs 982.72 crore during the previous quarter ended December 2022. ParticularsQuarter Ended�Dec. 2023Dec. 2022% Var. Sales996.32982.72 1 OPM %31.5029.88 - PBDT327.84298.72 10 PBT282.03251.48 12 NP258.41237.13 9 Powered by Capital Market - Live News

Emami will hold a meeting of the Board of Directors of the Company on 9 February 2024.Powered by Capital Market - Live News